Zhang W, Yuan M, Hong L, Zhou Q, Chen W, Yang S, Yang Q, Chen W, Yu X
Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Key Laboratory of Nephrology, Ministry of Health of China, Guangzhou, China.
Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Lupus. 2016 Dec;25(14):1532-1541. doi: 10.1177/0961203316642312. Epub 2016 Apr 7.
The prognostic significance of different proportions of crescents in lupus nephritis (LN) remains unclear. We assessed the long-term prognosis of LN patients with different proportions of crescents.
In this single-center, retrospective cohort study, 788 eligible LN patients were enrolled. The primary endpoint was doubling of baseline serum creatinine and end-stage renal disease; the secondary endpoint was death.
There were 406 (51.5%) patients demonstrating crescents at biopsy, and they had more severe baseline status: lower estimated glomerular filtration rate (eGFR), more proteinuria, more severe microscopic hematuria, and higher pathological scores for both activity index (AI) and chronicity index (CIn) (all p < 0.001, respectively). After a median follow-up period of 56 months (range: 3-172 months), no significant differences were observed in terms of renal or patient survival in these two groups (p = 0.188). In LN patients with crescents, patient survival was poorer along with the increase in the proportion of crescents; for crescentic LN, patient survival was 78.9% at five years and 52.6% at 10 years (vs. subgroups of crescent proportion <10%, 10%-19%, 20%-49%: 95.5%, 92.3%, 91.7% at five years; 86.1%, 80.1%, 66.5% at 10 years, respectively, p = 0.008). Furthermore, there were higher proportions of crescents independently predicted for adverse outcomes of renal progression and mortality (p = 0.049) after adjusting for age, sex, baseline eGFR, proteinuria, AI, and CIn in the multivariate Cox proportional hazard model.
The overall long-term renal survival of LN patients with and without crescents was comparable. However, a higher proportion of crescents increased the risk for unfavorable outcomes. Therefore, more attention should be paid to the lesions of crescents, and more prospective studies are needed to explore the optimal regimens for LN patients with different proportions of crescents.
狼疮性肾炎(LN)中不同比例新月体的预后意义仍不明确。我们评估了不同新月体比例的LN患者的长期预后。
在这项单中心回顾性队列研究中,纳入了788例符合条件的LN患者。主要终点是基线血清肌酐翻倍和终末期肾病;次要终点是死亡。
406例(51.5%)患者活检时出现新月体,且他们的基线状态更严重:估计肾小球滤过率(eGFR)更低、蛋白尿更多、镜下血尿更严重,活动指数(AI)和慢性指数(CIn)的病理评分更高(所有p均<0.001)。中位随访期56个月(范围:3 - 172个月)后,两组在肾脏或患者生存率方面未观察到显著差异(p = 0.188)。在有新月体的LN患者中,患者生存率随新月体比例增加而降低;对于新月体性LN,5年时患者生存率为78.9%,10年时为52.6%(与新月体比例<10%、10% - 19%、20% - 49%的亚组相比:5年时分别为95.5%、92.3%、91.7%;10年时分别为86.1%、80.1%、66.5%,p = 0.008)。此外,在多变量Cox比例风险模型中,调整年龄、性别、基线eGFR、蛋白尿、AI和CIn后,新月体比例较高独立预测肾脏进展和死亡的不良结局(p = 0.049)。
有新月体和无新月体的LN患者总体长期肾脏生存率相当。然而,较高比例的新月体增加了不良结局的风险。因此,应更多关注新月体病变,需要更多前瞻性研究来探索针对不同新月体比例LN患者的最佳治疗方案。